• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氨氯地平:双刃剑。

Amlodipine: The double edged sword.

作者信息

Rabah Fatma, El-Naggari Mohamed, Al-Nabhani Dana

机构信息

Child Health Department, Sultan Qaboos University Hospital, Muscat, Oman.

出版信息

J Paediatr Child Health. 2017 Jun;53(6):540-542. doi: 10.1111/jpc.13517. Epub 2017 Apr 7.

DOI:10.1111/jpc.13517
PMID:28387969
Abstract

AIM

Amlodipine, a calcium channel blocker became one of the most popular antihypertensive medications used in the paediatric population. This is mainly due to its long half-life making it easy to use as a single daily dose. Amlodipine is associated with common side effects like flushing, headache and dizziness. The incidence of amlodipine-related oedema was noted to be lower in the paediatric population compared to adults. We emphasise the importance of monitoring the development of oedema in patients treated with amlodipine.

METHODS

Hereby, we report four paediatric cases with amlodipine-related generalised oedema.

CONCLUSION

Resolution of the oedema with stoppage of amlodipine confirms its culprit as a cause of the oedema. To our knowledge, this is the largest case series of amlodipine-related generalised oedema in the paediatric population.

摘要

目的

氨氯地平,一种钙通道阻滞剂,成为儿科人群中最常用的抗高血压药物之一。这主要是由于其半衰期长,便于每日单次给药。氨氯地平会引发如潮红、头痛和头晕等常见副作用。与成人相比,氨氯地平相关水肿在儿科人群中的发生率较低。我们强调在接受氨氯地平治疗的患者中监测水肿发展情况的重要性。

方法

在此,我们报告4例与氨氯地平相关的全身性水肿的儿科病例。

结论

停用氨氯地平后水肿消退,证实其为水肿的病因。据我们所知,这是儿科人群中与氨氯地平相关的全身性水肿的最大病例系列。

相似文献

1
Amlodipine: The double edged sword.氨氯地平:双刃剑。
J Paediatr Child Health. 2017 Jun;53(6):540-542. doi: 10.1111/jpc.13517. Epub 2017 Apr 7.
2
Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension.两项多中心、为期8周、随机、双盲、安慰剂对照、平行组研究,评估氨氯地平和缬沙坦联合用药及单药治疗对轻度至中度原发性高血压成年患者的疗效和耐受性。
Clin Ther. 2007 Apr;29(4):563-80. doi: 10.1016/j.clinthera.2007.03.018.
3
Quantification of pedal edema during treatment with S(-)-amlodipine nicotinate versus amlodipine besylate in female Korean patients with mild to moderate hypertension: a 12-week, multicenter, randomized, double-blind, active-controlled, phase IV clinical trial.在患有轻中度高血压的韩国女性患者中,使用 S(-)-烟碱酸氨氯地平与苯磺酸氨氯地平治疗期间的足部水肿定量评估:一项为期 12 周、多中心、随机、双盲、阳性药物对照、四期临床试验。
Clin Ther. 2012 Sep;34(9):1940-7. doi: 10.1016/j.clinthera.2012.08.003. Epub 2012 Aug 25.
4
Preliminary experience with amlodipine in the pediatric population.氨氯地平在儿科人群中的初步经验。
Am J Ther. 2006 May-Jun;13(3):198-204. doi: 10.1097/01.mjt.0000147593.73888.d5.
5
Parallel comparative trial of amlodipine and nitrendipine monotherapy in patients with essential hypertension.氨氯地平和尼群地平单药治疗原发性高血压患者的平行对照试验
J Hypertens Suppl. 1998 Sep;16(4):S43-7.
6
Amlodipine once-daily in systemic hypertension.
Eur J Pediatr. 1998 Aug;157(8):618-21. doi: 10.1007/s004310050897.
7
Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: a comparative study of the efficacy and safety against amlodipine.缬沙坦,一种用于治疗原发性高血压的新型血管紧张素II拮抗剂:与氨氯地平疗效和安全性的对比研究。
Clin Pharmacol Ther. 1996 Sep;60(3):341-6. doi: 10.1016/S0009-9236(96)90061-2.
8
Efficacy and safety of a therapeutic interchange from high-dose calcium channel blockers to a fixed-dose combination of amlodipine/benazepril in patients with moderate-to-severe hypertension.中重度高血压患者从高剂量钙通道阻滞剂治疗转换为氨氯地平/贝那普利固定剂量联合治疗的疗效与安全性
J Hum Hypertens. 2001 Aug;15(8):559-65. doi: 10.1038/sj.jhh.1001230.
9
Efficacy and safety of two fixed-dose combinations of S-amlodipine and telmisartan (CKD-828) versus S-amlodipine monotherapy in patients with hypertension inadequately controlled using S-amlodipine monotherapy: an 8-week, multicenter, randomized, double-blind, Phase III clinical study.在使用苯磺酸氨氯地平单药治疗血压控制不佳的高血压患者中,两种固定剂量的苯磺酸氨氯地平与替米沙坦复方制剂(CKD-828)对比苯磺酸氨氯地平单药治疗的疗效和安全性:一项为期8周的多中心、随机、双盲、III期临床研究。
Drug Des Devel Ther. 2016 Nov 23;10:3817-3826. doi: 10.2147/DDDT.S116847. eCollection 2016.
10
Cyclosporin enhances the tendency towards oedema and flushing noted on dihydropyridine calcium channel blockers.环孢素增强了二氢吡啶类钙通道阻滞剂所引起的水肿和潮红倾向。
Br J Clin Pharmacol. 2002 Sep;54(3):334-5. doi: 10.1046/j.1365-2125.2002.01622.x.

引用本文的文献

1
The Dysfunction of Ca Channels in Hereditary and Chronic Human Heart Diseases and Experimental Animal Models.钙通道在遗传性和慢性人类心脏疾病及实验动物模型中的功能障碍。
Int J Mol Sci. 2023 Oct 27;24(21):15682. doi: 10.3390/ijms242115682.
2
Genetic Variation in and Affects Amlodipine Pharmacokinetics and Safety.[基因名称1]和[基因名称2]中的基因变异影响氨氯地平的药代动力学和安全性。 (注:原文中两个基因名称缺失,需根据实际情况补充完整)
Pharmaceutics. 2023 Jan 25;15(2):404. doi: 10.3390/pharmaceutics15020404.